June 24, 2026 article Open access Evaluating neoantigen-vaccine responses through mechanistic and model-based frameworks npj Precision Oncology DOI: 10.1038/s41698-026-01579-8 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 0 stored of 0 References 4 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Strong vaccine responses during chemotherapy are associated with prolonged cancer survival 2020 Science Translational Medicine article Immunology and Microbiology Immunotherapy and Immune Responses Open access cited by 2 patents 136 citations MC38 colorectal tumor cell lines from two different sources display substantial differences in transcriptome, mutanome and neoantigen expression 2023 Frontiers in Immunology article Medicine Cancer Immunotherapy and Biomarkers Open access cited by 5 patents 34 citations Results of a randomized, double-blind, placebo-controlled, phase 2 study (OpcemISA) of the combination of ISA101b and cemiplimab versus cemiplimab for recurrent/metastatic (R/M) HPV16-positive oropharyngeal cancer (OPC). 2024 Journal of Clinical Oncology conference-abstract Medicine Head and Neck Cancer Studies Open access 18 citations Cemiplimab plus peltopepimut-S vaccine in recurrent cervical cancer: A phase 2 clinical trial 2025 Gynecologic Oncology article Medicine Cervical Cancer and HPV Research Open access 10 citations 4 results